Expanding the phenotypic and biochemical spectrum of NDUFAF3-related mitochondrial disease.


Journal

Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456

Informations de publication

Date de publication:
11 2023
Historique:
received: 12 04 2023
revised: 27 07 2023
accepted: 30 07 2023
medline: 14 11 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

Recessive variants in NDUFAF3 are a known cause of complex I (CI)-related mitochondrial disorders (MDs). The seven patients reported to date exhibited severe neurologic symptoms and lactic acidosis, followed by a fatal course and death during infancy in most cases. We present a 10-year-old patient with a neurodevelopmental disorder, progressive exercise intolerance, dystonia, basal ganglia abnormalities, and elevated lactate concentration in blood. Trio-exome sequencing revealed compound-heterozygosity for a pathogenic splice-site and a likely pathogenic missense variant in NDUFAF3. Spectrophotometric analysis of fibroblast-derived mitochondria demonstrated a relatively mild reduction of CI activity. Complexome analyses revealed severely reduced NDUFAF3 as well as CI in patient fibroblasts. Accumulation of early sub-assemblies of the membrane arm of CI associated with mitochondrial complex I intermediate assembly (MCIA) complex was observed. The most striking additional findings were both the unusual occurrence of free monomeric CI holding MCIA and other assembly factors. Here we discuss our patient in context of genotype, phenotype and metabolite data from previously reported NDUFAF3 cases. With the atypical presentation of our patient, we provide further insight into the phenotypic spectrum of NDUFAF3-related MDs. Complexome analysis in our patient confirms the previously defined role of NDUFAF3 within CI biogenesis, yet adds new aspects regarding the correct timing of both the association of soluble and membrane arm modules and CI-maturation as well as respiratory supercomplex formation.

Identifiants

pubmed: 37572574
pii: S1096-7192(23)00305-0
doi: 10.1016/j.ymgme.2023.107675
pii:
doi:

Substances chimiques

Electron Transport Complex I EC 7.1.1.2
NDUFAF3 protein, human 0
Mitochondrial Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107675

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no competing interests.

Auteurs

Amelie T van der Ven (AT)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: a.vanderven@uke.de.

Alfredo Cabrera-Orefice (A)

Functional Proteomics, Institute of Cardiovascular Physiology, Goethe University, Frankfurt am Main, Germany.

Isabell Wente (I)

Functional Proteomics, Institute of Cardiovascular Physiology, Goethe University, Frankfurt am Main, Germany.

René G Feichtinger (RG)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.

Konstantinos Tsiakas (K)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Deike Weiss (D)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Tatjana Bierhals (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Leila Scholle (L)

Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Holger Prokisch (H)

Institute of Human Genetics, Klinikum Rechts der Isar, TUM, Munich, Germany.; Institute of Neurogenomics, Helmholtz Center Munich, Neuherberg, Germany.

Robert Kopajtich (R)

Institute of Human Genetics, Klinikum Rechts der Isar, TUM, Munich, Germany.; Institute of Neurogenomics, Helmholtz Center Munich, Neuherberg, Germany.

René Santer (R)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Johannes A Mayr (JA)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.

Ilka Wittig (I)

Functional Proteomics, Institute of Cardiovascular Physiology, Goethe University, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH